Should I buy or sell Opsens stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OPSSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPSSF, but not buy additional shares or sell existing shares. View OPSSF analyst ratings or view top-rated stocks .

How have OPSSF shares performed in 2024?

Opsens' stock was trading at $2.1389 on January 1st, 2024. Since then, OPSSF shares have increased by 0.0% and is now trading at $2.1389. View the best growth stocks for 2024 here .

How were Opsens' earnings last quarter?

Opsens Inc. (OTCMKTS:OPSSF) posted its quarterly earnings data on Tuesday, January, 21st. The company reported ($0.01) earnings per share for the quarter.

How do I buy shares of Opsens?

Shares of OPSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:OPSSF

Opsens (OPSSF) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

Free OPSSF Stock Alerts

$2.14

+0.01 (+0.64%)

(As of 12/13/2023)

Compare

Today's Range: $2.12
▼
$2.14
50-Day Range: $2.14
▼
$2.14
52-Week Range: $0.97
▼
$2.14

Volume: 36,000 shs
Average Volume: 44,497 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get Opsens alerts:

Ad Market Moving Trends

Top 5 AI Stocks to Buy for 2024

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

About Opsens Stock (OTCMKTS:OPSSF)

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada.

OPSSF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OPSSF Stock News Headlines

November 22, 2023 | marketwatch.com

Opsens 4Q Loss Narrows, Revenue Tops Views

November 2, 2023 | finance.yahoo.com

OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS

April 17, 2024 | Crypto 101 Media (Ad)

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

October 23, 2023 | finance.yahoo.com

OPSENS ANNOUNCES THE POSITIVE CLINICAL RESULTS FROM THE SAFE-TAVI STUDY WITH SAVVYWIRE IN EUROPE

October 17, 2023 | finance.yahoo.com

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023

October 5, 2023 | finance.yahoo.com

Opsens' (TSE:OPS) investors will be pleased with their impressive 150% return over the last three years

June 20, 2023 | finance.yahoo.com

OPS.TO - Opsens Inc.

April 20, 2023 | finance.yahoo.com

OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference

April 17, 2024 | Crypto 101 Media (Ad)

[Urgent!] Generational Wealth Gameplan

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

April 6, 2023 | finance.yahoo.com

OPSENS TO HOST SECOND QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY APRIL 13, 2023

February 28, 2023 | finance.yahoo.com

OPSENS ANNOUNCES SAVVYWIRE™ USED DURING TWO LIVE CASES AT CRT CONFERENCE

January 12, 2023 | finance.yahoo.com

OPSENS ANNOUNCES RECORD FIRST QUARTER FISCAL 2023 FINANCIAL RESULTS

January 11, 2023 | markets.businessinsider.com

Opsens earnings: here's what Wall Street expects

January 5, 2023 | finance.yahoo.com

OPSENS TO HOST FIRST QUARTER FISCAL YEAR 2023 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY JANUARY 12, 2023

December 22, 2022 | finance.yahoo.com

OPSENS ANNOUNCES CLOSING OF $11.5 MILLION BOUGHT DEAL PUBLIC OFFERING INCLUDING $1.5 MILLION OVER-ALLOTMENT OPTION EXERCISED IN FULL

November 29, 2022 | finance.yahoo.com

OPSENS ANNOUNCES FIRST SAVVYWIRE™ PROCEDURE IN NEW ZEALAND

September 15, 2022 | finance.yahoo.com

Promaxo Announces Research Collaboration with the University of Montreal Hospital Research Centre (CRCHUM) for Improved Prostate, Female GYN Cancer Management - Yahoo Finance

September 15, 2022 | finance.yahoo.com

Inhibikase Therapeutics to Present Data from Phase 1/1b study of IkT-148009 at the Movement Disorders Society Congress - Yahoo Finance

September 15, 2022 | finance.yahoo.com

OPSENS ANNOUNCES FDA CLEARANCE FOR THE SAVVYWIRE™ FOR USE IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) PROCEDURES

September 14, 2022 | finance.yahoo.com

OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022 - Yahoo Finance

August 21, 2022 | finance.yahoo.com

Opsens Inc. (OPSSF)

July 15, 2022 | seekingalpha.com

Opsens GAAP EPS of -$0.03, revenue of $10.1M beats by $3.01M (OTCMKTS:OPSSF) - Seeking Alpha

July 14, 2022 | finance.yahoo.com

OPSENS ANNOUNCES THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS WITH RECORD QUARTERLY REVENUES - Yahoo Finance

July 11, 2022 | finance.yahoo.com

OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III

July 7, 2022 | finance.yahoo.com

OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JULY 14

May 20, 2022 | yahoo.com

10 Summer Grocery Deals at Target

April 13, 2022 | finance.yahoo.com

OPSENS ANNOUNCES SECOND QUARTER FISCAL 2022 FINANCIAL RESULTS

See More Headlines

Receive OPSSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 1/21/2014
Today: 4/17/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Instruments & Supplies
Sub-Industry: N/A
Current Symbol: OTCMKTS:OPSSF
CUSIP: N/A
CIK: N/A
Web: opsens.com
Phone: (418) 781-0333
Fax: N/A
Employees: 293
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Alan W. Milinazzo (Age 63)
Executive Chairman of the Board
Comp: $73.47k
Mr. Louis Laflamme C.A.
CPA, CPA, CEO, President & Director
Mr. Brad Davis
Chief Commercial Officer
Mr. John Hannigan
Chief Financial Officer
Mr. Pierre Poulin
Corporate Controller

Key Competitors

View All Competitors

OPSSF Stock Analysis - Frequently Asked Questions

Should I buy or sell Opsens stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" OPSSF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OPSSF, but not buy additional shares or sell existing shares.
View OPSSF analyst ratings or view top-rated stocks.
How have OPSSF shares performed in 2024?: Opsens' stock was trading at $2.1389 on January 1st, 2024. Since then, OPSSF shares have increased by 0.0% and is now trading at $2.1389.
View the best growth stocks for 2024 here.
How were Opsens' earnings last quarter?: Opsens Inc. (OTCMKTS:OPSSF) posted its quarterly earnings data on Tuesday, January, 21st. The company reported ($0.01) earnings per share for the quarter.
How do I buy shares of Opsens?: Shares of OPSSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OPSSF) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Opsens (OPSSF) Stock Price, News & Analysis

About Opsens Stock (OTCMKTS:OPSSF)

OPSSF Stock Price History

OPSSF Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

OPSSF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info